Primatene Mist sales grew by 20%, signaling strong market demand. FDA accepted a Biologics License Application for insulin aspart. The company continues to focus on diversifying its product portfolio.

Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic for type 1 diabetes that overcomes the need to obtain islet cells from ...

More Chaos tallied just 59,500 equivalent album units, but because it didn't have a ton of fresh high-profile competition, that was enough to land it on top of the charts. No new songs enter the ...

A group of experts updated the FITTER insulin injection recommendations for the first time since 2016. The report includes new guidance on needle size and the angle at which injections should be ...

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...

This involves taking both insulin and non-insulin oral medications. This chart describes the different types of insulin and how they can affect you. Within each category, there are different ...

Potential Weakness: The potential weakness of the studies is that they were of relatively short duration (≤24 weeks) and so the long-term effects of insulin aspart in CSII cannot be assessed.

Insulin resistance is a growing health concern worldwide, linked to a variety of conditions such as type 2 diabetes, polycystic ovary syndrome (PCOS), Alzheimer's disease, metabolic syndrome, and ...

(MENAFN- PR Newswire) Under the terms of the agreement, Biocon Biologics will supply Insulin Aspart drug substance to Civica, Inc., who will use the drug substance to produce Insulin Aspart drug ...